14th February 2019: Dr Antoinette Perry receiving official award of Commercialisation Fund from Deirdre Glenn, Director, Lifesciences & Food Commercialisation at Enterprise Ireland for project entitled, “epiCaPture: a urine test to detect aggressive prostate cancer”.
-
Cancer Research News- Researchers uncover new role of mutant RAS proteins in some of the deadliest cancers November 11, 2024
- NIH-funded scientists uncover clues to precancer and tumor biology October 30, 2024
- NIH clinical trial will test precision medicine treatments for myeloid cancers October 23, 2024
- New cancer diagnoses did not rebound as expected following pandemic September 24, 2024
- Immunotherapy after surgery helps people with high-risk bladder cancer live cancer-free longer September 16, 2024
- NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry September 16, 2024
- Immunotherapy approach shows potential in some people with metastatic solid tumors July 11, 2024
- For healthy adults, taking multivitamins daily is not associated with a lower risk of death June 26, 2024
- Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma June 19, 2024
- Inherited genetic factors may predict the pattern of X chromosome loss in older women June 12, 2024